BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27461908)

  • 1. Do we really need herbal medicine in LUTS/BPH treatment in the 21
    Pinggera GM; Frauscher F
    Expert Opin Drug Saf; 2016 Dec; 15(12):1573-1575. PubMed ID: 27461908
    [No Abstract]   [Full Text] [Related]  

  • 2. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serenoa repens for benign prostatic hyperplasia.
    Tacklind J; Macdonald R; Rutks I; Stanke JU; Wilt TJ
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD001423. PubMed ID: 23235581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
    Ooi SL; Pak SC
    J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review.
    MacDonald R; Tacklind JW; Rutks I; Wilt TJ
    BJU Int; 2012 Jun; 109(12):1756-61. PubMed ID: 22551330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
    Latil A; Pétrissans MT; Rouquet J; Robert G; de la Taille A
    Prostate; 2015 Dec; 75(16):1857-67. PubMed ID: 26306400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptoms.
    De Monte C; Carradori S; Granese A; Di Pierro GB; Leonardo C; De Nunzio C
    BMC Urol; 2014 Aug; 14():63. PubMed ID: 25112532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    De Nunzio C; Salonia A; Gacci M; Ficarra V
    World J Urol; 2020 Nov; 38(11):2771-2779. PubMed ID: 32060633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials.
    Russo GI; Scandura C; Di Mauro M; Cacciamani G; Albersen M; Hatzichristodoulou G; Fode M; Capogrosso P; Cimino S; Marcelissen T; Cornu JN; Gacci M; Minervini A; Cocci A;
    Eur Urol Focus; 2021 Mar; 7(2):420-431. PubMed ID: 31952967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study.
    Cai T; Morgia G; Carrieri G; Terrone C; Imbimbo C; Verze P; Mirone V;
    Arch Ital Urol Androl; 2013 Dec; 85(4):184-9. PubMed ID: 24399119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of Serenoa repens treatment in patients with mild and moderate symptomatic benign prostatic hyperplasia.
    Sinescu I; Geavlete P; Multescu R; Gangu C; Miclea F; Coman I; Ioiart I; Ambert V; Constantin T; Petrut B; Feciche B
    Urol Int; 2011; 86(3):284-9. PubMed ID: 21304222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytotherapy for male luts: What happens then? 10-year research.
    Luciani LG; Mattevi D; Vattovani V; Cai T; Giusti G; Malossini G
    Actas Urol Esp (Engl Ed); 2022 Sep; 46(7):442-446. PubMed ID: 35337768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editorResponse to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1-10.
    Arena S
    Expert Opin Drug Saf; 2016 Oct; 15(10):1449. PubMed ID: 27558894
    [No Abstract]   [Full Text] [Related]  

  • 15. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
    Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
    Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
    Morgia G; Russo GI; Voce S; Palmieri F; Gentile M; Giannantoni A; Blefari F; Carini M; Minervini A; Ginepri A; Salvia G; Vespasiani G; Santelli G; Cimino S; Allegro R; Collura Z; Fragalà E; Arnone S; Pareo RM
    Prostate; 2014 Nov; 74(15):1471-80. PubMed ID: 25154739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
    Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
    Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms].
    Amdii RE; Al' Shukri AS
    Urologiia; 2018 May; (2):114-120. PubMed ID: 29901305
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Trivisonno LF; Sgarbossa N; Alvez GA; Fieiras C; Escobar Liquitay CM; Jung JH; Franco JVA
    Investig Clin Urol; 2021 Sep; 62(5):520-534. PubMed ID: 34488251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review.
    Damiano R; Cai T; Fornara P; Franzese CA; Leonardi R; Mirone V
    Arch Ital Urol Androl; 2016 Jul; 88(2):136-43. PubMed ID: 27377091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.